GLP Watchdog

Compounding Pharmacy · Franklin, TN · 503A

DCA Pharmacy Review

Franklin, TN, and among the largest 503A compounding pharmacies in Tennessee, DCA ships under license to 48 states. Its lines are pellet therapy, scar therapy, topical pain management, bio-identical hormone replacement, and sterile compounding. Novo Nordisk named the pharmacy in a 2023 lawsuit over compounded semaglutide; that case ended in a voluntary dismissal.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

503AState pharmacy license
Location: Franklin, TN
States licensed: 49
6.0
★★★☆☆3/5

Our own score · methodology

GLP-1 Partners We Score Highest

None of these fill through DCA Pharmacy. They are the compounded GLP-1 partners at the top of our own scoring, here in case you would rather start with a service we have taken through signup ourselves.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

Cash-pay pricing · HSA/FSA accepted · every partner checked by our editors

6.7

Eden

Coverage in all 50 states, which most sellers will not confirm

Starting price: $189/mo

Get started →Read review Eden →
8.3

SnagRx

Semaglutide at $99/month, 48% below the typical price

Starting price: $69/mo

Get started →Read review SnagRx →
9.3

Embody

Knowing which pharmacy fills the vial: it names RedRock Pharmacy

Starting price: $79/mo

Get started →Read review Embody →
8.2

YourEra

Semaglutide at $99/month, 63% below the typical price

Starting price: $99/mo

Get started →Read review YourEra →

Accreditations and Standards

Sterile compounding in this country runs on one rulebook, General Chapter <797> of the United States Pharmacopeia[4]. Depending on what is being made, the finished preparation is then tested for sterility under USP <71>[5] and for bacterial endotoxins under USP <85>[6]. Every pharmacy on this page owes those standards already. What follows is what this one has added on top.

State pharmacy license
The home state board of pharmacy has issued a license. Every pharmacy in the country needs one to open its doors, so treat this as the floor rather than a distinction.
503A
A Section 503A pharmacy. It compounds against a prescription written for one named patient, and its day-to-day regulator is the state board of pharmacy rather than the FDA.

What It Compounds

Whether any pharmacy may compound semaglutide or tirzepatide at all turns on where the reference product sits on the FDA Drug Shortage List. When a drug comes off that list the door closes, and it has closed before[7].

Semaglutide
Compounds semaglutide
Tirzepatide
Compounds tirzepatide

States Licensed (49)

ALAKAZARCACOCTDEFLGAHIIDILINIAKSKYLAMEMDMAMIMNMSMOMTNENVNHNJNMNYNCNDOHOKORPARISDTNTXUTVTVAWAWVWIWY

What Regulators Have on File

2023-XX-XX
Named in Novo Nordisk Inc. v. DCA Pharmacy, Case No. 3:23-cv-00668 (M.D. Tenn. 2023), alleging trademark infringement on compounded semaglutide marketing. Novo voluntarily dismissed the case; DCA remains operationally active.

How GLP Watchdog Scored This Pharmacy

Accreditation held6/10
Standing with regulators5/10
States licensed10/10
GLP-1 compounding10/10
Years operating5/10

We research every score ourselves. The methodology page sets out how each part is weighted.

Medium confidence · Last verified 2026-05-23 via pharmacy-directory-cross-state-audit-2026-05-23 · How we check provider data

Frequently Asked Questions

Here is what we can and cannot confirm. DCA Pharmacy operates as a 503A compounding pharmacy out of Franklin, TN. Its authority to operate rests on a state board of pharmacy license and nothing further. Our records carry 1 documented regulatory action(s), listed further down this page.
DCA Pharmacy works out of Franklin, TN. It holds licenses to ship into 49 US states.
Alongside its other compounded preparations, DCA Pharmacy makes compounded semaglutide and compounded tirzepatide. Being a 503A pharmacy, it compounds only against a prescription written for one named patient, with the state board of pharmacy watching.
Two things separate them: who inspects, and how much may be made at once. A 503B outsourcing facility registers with the FDA itself, works to current Good Manufacturing Practices (cGMP), submits to FDA inspection, and may make compounded medication in batches with no named patient attached. A 503A pharmacy cannot do that. It fills a prescription written for one patient, answers mainly to its state board of pharmacy, and works to the USP <797> standard for sterile compounding. Neither route produces an FDA-approved drug.

Glossary

The words sellers use, defined. Tap any term.

Where to fill semaglutideBack to the register
Sources & methodology — as of September 2026
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.